Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin in severe acute alcoholic hepatitis (pilot study)
2012-000515-80Phase 2Completed
- Sponsor
- Juan Córdoba
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of rifaximin in alcoholic hepatitis (AH) (2 arms), sponsored by Juan Córdoba. Primary endpoint: bacterial infections. Started Jun 2012; status: completed.
02
Drugs
rifaximin
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on 2012-000515-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000515-80.